Posted on 1/8/19
Divurgent and Gevity Announce Strategic Business Alliance
Today, Divurgent and Gevity, two leading healthcare IT consulting firms, announced that they have formalized a strategic business alliance to mutually benefit their clients by expanding . . .
Posted on 1/8/19
Ascentage Pharma Announces New License with Unity Biotechnology
Ascentage Pharma, a global clinical-stage biopharmaceutical company dedicated to developing apoptosis-targeted therapies for cancers and other diseases, today announced that Unity Biotechnology, Inc. (Nasdaq:UBX) has selected . . .
Posted on 1/7/19
Beam-Signing and Topping Out Ceremony for AAMC’s New Mental Health Hospital
WHAT: Anne Arundel Medical Center (AAMC) celebrates a milestone in the construction of its new mental health hospital by placing the last piece of steel into . . .
Posted on 1/4/19
RegeneRx Update on Dry Eye and EB Clinical Trials
ROCKVILLE, Md., Jan. 4, 2019 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage drug development company focused on tissue protection, repair and regeneration, is updating . . .
Posted on 1/4/19
Regenxbio: Is This The Best Performing Stock For 2019?
Summary 2018 was a memorable year for the bioscience sector, as the bear market created many bargain opportunities. 2019 is likely to produce more bargain stocks . . .
Posted on 1/4/19
REGENXBIO Reports Continued Progress Across Programs in Year-End 2018 Corporate Update
REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV Technology . . .
Posted on 1/3/19
VenatoRx Pharmaceuticals Joins Antimicrobials Working Group
The Antimicrobials Working Group (AWG) announced today the addition of VenatoRx Pharmaceuticals, Inc. to its coalition of companies with the mission to combat drug resistant infections . . .
Posted on 1/3/19
Horizon Pharma plc and HemoShear Therapeutics Enter into Exclusive Drug Discovery Collaboration in Gout
DUBLIN & CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Horizon Pharma plc (Nasdaq: HZNP) and HemoShear Therapeutics, LLC, a privately held biotechnology company, today announced a collaboration to discover and develop . . .
Posted on 1/2/19
Omega Healthcare Investors To Acquire MedEquities Realty Trust
HUNT VALLEY, Md. & NASHVILLE, Tenn.--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE: OHI) and MedEquities Realty Trust, Inc. (NYSE: MRT) today announced the execution of a definitive . . .
Posted on 12/20/18
Altria Makes $12.8 Billion Minority Investment in JUUL
Altria Group, Inc. (Altria) (NYSE:MO) today announces it signed and closed a $12.8 billion investment in JUUL Labs, Inc.
Posted on 12/18/18
Altimmune Reports Mixed Bag Of Updates
Summary Altimmune recently reported mixed data on their NasoShield and HepTcell programs. I take a look at the press release to extract the good and the . . .
Posted on 12/18/18
Emergent BioSolutions Receives Health Canada Approval of BioThrax
GAITHERSBURG, Md., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that Health Canada has approved the company’s New Drug Submission (NDS) for . . .
Posted on 12/17/18
AbleVets Is a 2018 Best Workplace for Commuters in Fairfax County
Board of Supervisors recognizes this achievement at a recent ceremonyWyatt SmithAbleVets LLC, a leading provider of health IT solutions for government, today announced that it is . . .
Posted on 12/17/18
Precision Medicine Group Acquires Stern Investor Relations
Precision Medicine Group, Inc. (Precision) today announced it has acquired Stern Investor Relations, Inc. (Stern IR), a leading investor relations firm for entrepreneurial biotechnology
Posted on 12/14/18
NW Bio Announces That UK Property Transaction Has Closed
Northwest Biotherapeutics (OTCQB: NWBO) -- a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that the package transaction involving the Company's UK . . .
Posted on 12/14/18
NW Bio Announces That UK Property Transaction Has Closed
Northwest Biotherapeutics (OTCQB: NWBO) -- a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that the package transaction involving the Company's UK . . .
Posted on 12/14/18
Why Ciena Stock Jumped Thursday
What happenedShares of network strategy and technology company Ciena (NYSE:CIEN) jumped on Thursday, rising as much as 13.8%. As of 10:53 a.m. EST, the stock was . . .
Posted on 12/14/18
Ciena Corporation (CIEN) Q4 2018 Earnings Conference Call Transcript
IMAGE SOURCE: THE MOTLEY FOOL.Ciena Corporation (NYSE:CIEN)Q4 2018 Earnings Conference CallDec. 13, 2018, 8:30 a.m. ETContents:Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood morning. My name is Sharon, . . .
Posted on 12/14/18
Diffusion Pharmaceuticals Announces 1-for-15 Reverse Stock Split As Part Of NASDAQ Compliance Plan
CHARLOTTESVILLE, Va., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN), a cutting-edge biotechnology company developing new treatments for life-threatening medical conditions by improving . . .
Posted on 12/13/18
VLP Therapeutics Awarded $3.9 million Grant by Global Health Innovative Technology Fund
The Global Health Innovative Technology (GHIT) Fund has awarded VLP Therapeutics a $3.9 million grant to further develop a novel tetravalent dengue virus-like particle vaccine. "The . . .
Posted on 12/13/18
Adaptive Phage Therapeutics Enters into Collaboration Agreement with Researchers at Yale University
GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic . . .
Posted on 12/13/18
Orgenesis Announces Collaboration with Ben-Gurion University
GERMANTOWN, Md. and BEER-SHEVA, Israel, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS), a developer of advanced cell therapies, manufacturer and service provider, along . . .
Posted on 12/11/18
MacKenzie Contracting Completes ChoiceOne Urgent Care Center
MacKenzie Contracting Company, LLC, the full-service construction arm of MacKenzie Ventures, is pleased to announce they have completed work on the area’s latest ChoiceOne Urgent Care . . .
Posted on 12/11/18
Histo-Scientific Research Laboratories and Vet Path Services Merge
Histo-Scientific Research Laboratories, Inc. (HSRL), has completed its merger with Vet Path Services (VPS) to create the leading provider of research
Posted on 12/11/18
NW Bio Announces Non-Dilutive Funding of Approximately $47.3 Million Through UK Property Transaction
Northwest Biotherapeutics (OTCQB: NWBO) --, a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, announced today that it has entered into agreements with . . .

